Your browser doesn't support javascript.
loading
In Vivo Efficacy of Meropenem with a Novel Non-ß-Lactam-ß-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model.
Monogue, Marguerite L; Giovagnoli, Sara; Bissantz, Caterina; Zampaloni, Claudia; Nicolau, David P.
Afiliação
  • Monogue ML; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
  • Giovagnoli S; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
  • Bissantz C; Division of Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Zampaloni C; Division of Pharmaceutical Science, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Nicolau DP; Division of Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Antimicrob Agents Chemother ; 62(9)2018 09.
Article em En | MEDLINE | ID: mdl-30012751
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Urinárias / Beta-Lactamases / Farmacorresistência Bacteriana Múltipla / Inibidores de beta-Lactamases / Meropeném / Bactérias Gram-Negativas / Antibacterianos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Urinárias / Beta-Lactamases / Farmacorresistência Bacteriana Múltipla / Inibidores de beta-Lactamases / Meropeném / Bactérias Gram-Negativas / Antibacterianos Idioma: En Ano de publicação: 2018 Tipo de documento: Article